Ariel Investments released their second-quarter 2025 investor letter, noting extreme market fluctuations. The Ariel Global Fund traded 7.38% higher in the quarter, outperforming the MSCI ACWI Index. Top five holdings include Zimmer Biomet Holdings, Inc., a leading medical technology company with a one-month return of 6.23%.

In the investor letter, Ariel Global Fund highlighted Zimmer Biomet Holdings, Inc.’s struggle to maintain market share but expects growth with new product launches. The stock closed at $99.12 per share on September 16, 2025, with a market cap of $19.635 billion. Hedge funds are buying into Zimmer Biomet Holdings, Inc., with 40 portfolios holding the stock in the second quarter.

Despite Zimmer Biomet Holdings, Inc.’s potential, some AI stocks offer greater upside potential. The company reported net sales of $2.077 billion in the second quarter. Investors seeking undervalued AI stocks may find opportunities in companies benefiting from Trump-era tariffs and the onshoring trend.

Read more at Yahoo Finance: Do You Believe in the Upside Potential of Zimmer Biomet Holdings (ZBH)?